CLIA lab

CLIA 50D2276741: Affect Therapeutics Inc

Vancouver, WA. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 50D2276741 belongs to Affect Therapeutics Inc in Vancouver, WA.

Certificate of Waiver, effective February 14, 2023, expires April 4, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
February 14, 2023
Certificate expiration
April 4, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
February 14, 2023
Facility type
Comprehensive outpatient rehab facility
Ownership (control type)
Proprietary
Lab classification
CLIA exempt laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
50D2276741
Lab name
Affect Therapeutics Inc
Address
1112 Daniels St Bsmt Ste, Vancouver, WA 98660
Phone
(845) 769-8758
Fax
(888) 398-1839

Annual test volume the lab reported

Waived tests
1,000

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Vancouver, WA

Related

Questions

What is the CLIA number for Affect Therapeutics Inc in Vancouver?

50D2276741, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Affect Therapeutics Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 50D2276741 expire?

The CMS file lists April 4, 2028 as the certificate expiration date; the certificate took effect February 14, 2023.

Try it on your own data today.

Free to start. Most teams are using it the same day.